<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="102070">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01775722</url>
  </required_header>
  <id_info>
    <org_study_id>NIH/LAMMP-2012-9092</org_study_id>
    <nct_id>NCT01775722</nct_id>
  </id_info>
  <brief_title>Combined Bipolar Radiofrequency&amp;Pulsed Dye Laser Treatment</brief_title>
  <official_title>Combined Bipolar Radiofrequency and Pulsed Dye Laser Treatment of Port Wine Stain Birthmarks</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of California, Irvine</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Candela Corporation</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
    <collaborator>
      <agency>Beckman Laser Institute University of California Irvine</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of California, Irvine</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Port wine stain Birthmark is a congenital, progressive vascular malformation of human skin.
      However, even though the pulsed dye laser is considered as the treatment of choice for Port
      wine stain Birthmark the degree of fading can remain variable and unpredictable after laser
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The researcher want to use the combination of radiofrequency electrical energy with pulsed
      dye laser light energy which can improve therapeutic outcome of Port wine stain Birthmark.
      This investigational device is essentially a combination of two commercially available
      systems cleared for marketing (K044351 and K052324) provided by Candela Laser Corporation.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>December 2012</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>combined radiofrequency electrical energy with pulsed dye laser will improve Port wine stain outcome</measure>
    <time_frame>up to 12 months</time_frame>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Port-Wine Stain</condition>
  <arm_group>
    <arm_group_label>port wine stain</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>port wine stain</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>port wine stain</intervention_name>
    <description>port wine stain</description>
    <arm_group_label>port wine stain</arm_group_label>
    <other_name>candela-Laser</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Port Wine Stain suitable for comparison testing

          2. Age &gt; 12 years of age; minor will be accompanied in the room by parents or guardians
             during laser treatment

          3. Apparent good health as documented by medical history

          4. Ability to understand and carry out subject instructions

        Exclusion Criteria:

          1. History of photodermatoses or skin cancer

          2. Any therapy within the previous two months to the proposed port wine stain treatment
             sites

          3. Current participation in any other investigational drug or device evaluation

          4. Concurrent use of known photosensitizing drugs

          5. Inability to understand and carry out instructions
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>J. Stuart Nelson, M.D., Ph.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Beckman Laser Institute, UCI</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Montana Compton, RN</last_name>
    <phone>949-824-9265</phone>
    <email>mocomton@uci.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Beckman Laser Institute Medical Clinic</name>
      <address>
        <city>Irvine</city>
        <state>California</state>
        <zip>92612</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Montana Compton, RN</last_name>
      <phone>949-824-9265</phone>
      <email>mocomton@uci.edu</email>
    </contact>
    <investigator>
      <last_name>John Stuart Nelson, MD, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Wangcun Jia, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Montana Compton, RN</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <lastchanged_date>August 4, 2015</lastchanged_date>
  <firstreceived_date>January 14, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Irvine</investigator_affiliation>
    <investigator_full_name>Beckman Laser Institute and Medical Center</investigator_full_name>
    <investigator_title>J.S.Nelson, MD,PhD,Professor of Surgery and Biomedical Engineering</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Port-Wine Stain</mesh_term>
    <mesh_term>Hemangioma, Capillary</mesh_term>
    <mesh_term>Vascular Malformations</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
